Selected Reading
- Berenson JR et al: Efficacy of pamidronate in reducing skeletal events In patients with advanced multiple myeloma. N Engl J Med 334:488, 1996
- Diel IJ et al: Reduction In new metastases in breast cancer with adjuvant clodronate treatment. New Engl J Med 339:357, 1998
- Guise TA, Mundy GR: Cancer and bone. Endocrine Reviews 19:18, 1998
- Hortobagyi GN et al: Efficacy of Pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. New Engl J Med 335:1785, 1996
- Massagué J: TGF-β signal transduction. Annu Rev Biochem 67:753, 1998
- Mundy GR, Yoneda T: Bisphosphonates as anticancer drugs. New Engl J Med 339:398, 1998
- Sasaki A et al: Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice. Cancer Res 55:3551, 1995
- Yin J J et al: TGF-β signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. J Clin Invest 103:197, 1999